Mycoplasma pneumonia: Clinical features and management

Lung India

Volumn 27, Issue 2, 2010, Pages 75-85

  Kashyap, Surender ^a   Sarkar, Malay ^a  

^a INDIRA GANDHI MEDICAL COLLEGE   (India)

Author keywords

Asthma; Macrolides; Mollicuites mycoplasma; Serology

Indexed keywords

AZITHROMYCIN; BACTERIAL VACCINE; BETA LACTAM ANTIBIOTIC; CETHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; CORTICOSTEROID; ERYTHROMYCIN; GATIFLOXACIN; GEMIFLOXACIN; IMMUNOGLOBULIN; JOSAMYCIN; LEVOFLOXACIN; MACROLIDE; MINOCYCLINE; MOXIFLOXACIN; MYCOPLASMA PNEUMONIA VACCINE; NALIDIXIC ACID; PENICILLIN G; POLYMYXIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; ROXITHROMYCIN; SULFONAMIDE; TELITHROMYCIN; TETRACYCLINE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIGEN DETECTION; ASTHMA; BACTERIAL PNEUMONIA; BACTERIUM CULTURE; CLINICAL FEATURE; CLINICAL TRIAL; COMPLEMENT FIXATION TEST; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE TRANSMISSION; DNA PROBE; ENZYME IMMUNOASSAY; EPIDEMIC; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; MYELITIS; NONHUMAN; PATHOPHYSIOLOGY; PLASMAPHERESIS; PNEUMONIA; POLYMERASE CHAIN REACTION; POLYRADICULITIS; REVIEW; SEROLOGY;

EID: 77953466599     PISSN: 09702113     EISSN: 0974598X     Source Type: Journal    
DOI: 10.4103/0970-2113.63611     Document Type: Review

References (78)

1. Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Rev 1998;63:1094-1156
2. Rottem S. Interaction of mycoplasmas with host cellsphysiological. Review 2003;83:417-432
3. Maniloff J. Phylogeny of mycoplasmas. Mycoplasmas molecular biology and pathogenesis. In: Maniloff J, McElhaney RN, Finch LR, editors. Washington DC: American Society for Microbiology; 1992. p. 549-559
4. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 2004;17:697-728.
5. Foy HM, Cooney MK, McMahan R, Grayston JT. Viral and mycoplasmal pneumonia in a prepaid medical group during an eight year period. Am J Epidemiol 1973;97:93-102.
6. Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev 2008;32:956-973
7. Lind K, Benzon MW, Jensen JS, Clyde WA Jr. A sero epidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946-1995. Eur J Epidemiol 1997;13:581-586
8. Dorigo-Zetsma JW, Dankert J, Zaat SA. Genotyping of Mycoplasma pneumoniae clinical isolates reveals eight P1 subtypes within two genomic groups. J Clin Microbiol 2000;38:965-970
9. Jacobs E. Mycoplasma pneumoniae disease manifestations and epidemiology. In: Razin S, Herrman R, editors. Molecular biology and pathogenesis of mycoplasmas. New York: Kluwer Academic/Plenum Publishers; 2002. p. 519-530
10. Kashyap B, Kumar S, Sethi GR, Das BC, Saigal SR. Comparison of PCR, culture and serological tests for the diagnosis of Mycoplasma pneumoniae in community acquired lower respiratory tract infections infections in children. Indian J Med Res 2008;128:134-139
11. Bansal S, Kashyap S, Pal LS, Goel A. clinical and bacteriological profile of community acquired pneumonia in Shimla, Himachal Pradesh. Indian J Chest Dis Allied Sci 2004;46:17-22.
12. Shenoy VD, Upadhyaya SA, Rao SP, Shobha KL. Mycoplasma pneumoniae infection in children with acute respiratory infection. J Trop Pediatr 2005;51:232-235
13. Chaudhry R, Nazima N, Dhawan B, Kabra SK. Prevalence of Mycoplasma pneumoniae and chlamydia pneumoniae in children with community acquired pneumonia. Indian J Pediatr 1998;65:717-721
14. Ferwerda A, Moll HA, de Groot R. Respiratory tract infections by Mycoplasma pneumoniae in children: A review of diagnostic and therapeutic measures. Eur J Pediatr 2001;160:483-491
15. Foy HM, Grayston JT, Kenny GE. Epidemiology of Mycoplasma pneumoniae infection in families. JAMA 1966;197:859-866
16. Cimolai N, Wensley D, Thomas ET. Mycoplasma pneumoniae as a cofactor in severe respiratory infections. Clin Infect Dis 1995;21:1182-1185
17. Dey AB, Chaudhry R, Kumar P, Nisar N, Nagarkar KM. Mycoplasma pneumoniae and community acquired pneumonia. Nat Med J India 2000;13:66-70.
18. Staugas R, Martin AJ. Secondary bacterial infections in children with proved Mycoplasma pneumonia. Thorax 1985;40:546-548
19. Marston BJ, Plouffe JF, File TM Jr, Hackman BA, Salstrom SJ, Lipman HB, et al. Incidence of community acquired pneumonia requiring hospitalization: Results of a population based active surveillance study in Ohio: The community based pneumonia incidence study group. Arch Intern Med 1997;157:1709-1718
20. Vervloet LA, Marguet C, Camargos PA. Infection by Mycoplasma pneumoniae and its importance as an etiological agent in childhood community acquired pneumonias. Braz J Infect Dis 2007;11:507-514
21. Cassell GH, Clyde WA Jr, Davis JK. Mycoplasma respiratory infections. In: Razin S, Barile MF, editors. The mycoplasma. Vol.4. New York: Academic Press; 1985. p. 65-106.
22. Kountouras D, Deutsch M, Emmanuel T, Georgiadis G, Koskinas J. Fulminant Mycoplasma pneumoniae infection with multi-organ involvement: A case report. Eur J Intern Med 2003;14:329-331
23. Chan ED, Welsh CH. Fulminant Mycoplasma pneumoniae pneumonia. Western J Med 1995;162:133-142
24. Koletsky RJ, Weinstein AJ. Fulminant Mycoplasma pneumoniae infection: Report of a fatal case and a review of the literature. Am Rev Respir Dis 1980;122:491-496
25. Leonardi S, Pavone P, Rotolo N, La Rosa M. Stroke in two children with Mycoplasma pneumoniae infection: A casual or causal relationship? Pediatr Infect Dis J 2005;24:843-845
26. Guleria R, Nisar N, Chawla TC, Biswas NR. Mycoplasma pneumoniae and central nervous system complications: A review. J Lab Clin Med 2005;146:55-63.
27. Tsiodras S, Kelesidis I, Kelesidis T, Stamboulis E, Giamarellou H. Central nervous system manifestations of Mycoplasma pneumoniae infections. J Infect 2005;51:343-354
28. Sánchez-Vargas FM, Gómez-Duarte OG. Review Mycoplasma pneumoniae: An emerging extra-pulmonary pathogen. Clin Microbiol Infect 2008;14:105-115
29. Levine DP, Lemer AM. The clinical spectrum of Mycoplasma pneumoniae infections. Med Clin North Am 1978;62:961-978
30. Vanfleteren I, Van Gysel D, De Brandt C. Stevens-Johnson syndrome: A diagnostic challenge in the absence of skin lesions. Pediatr Dermatol 2003;20:52-56
31. Yong-Kwang T, Clark Huff J, Wilfiam L. Weston Mycoplasma pneumoniae infection is associated with Stevens-Johnson syndrome, not erythema multiforme. J Am Acad Dermatol 1996;35:757-760
32. Latsch K, Girschick HJ, Abele-Horn M. Stevens-Johnson syndrome without skin lesions. J Medical Microbiol 2007;56:1696-1699
33. Josef D. Schwarzmeier: A potentially fatal complication of Mycoplasma pneumoniae infection: The hemophagocytic syndrome. Respiration 2002;69:14-15
34. Jayantha UK. Mycoplasma pneumoniae infection in Sri Lanka. Sri Lanka J Child Health 2007;36:43-47
35. Zou CC. Multiple hypoechoic lesions in spleen and Mycoplasma pneumoniae infection. Indian Paediatr 2005;42:379-382
36. Blasi F, Tarsia P, Aliberti S, Cosentini R, Allegra L. Chlamydia pneumoniae and Mycoplasma pneumoniae. Semin Respir Critical Care Med 2005;26:617-624
37. Smith R, Eviatar L. Neurologic manifestations of Mycoplasma pneumoniae infections: Diverse spectrum of diseases: A report of six cases and review of the literature. Clin Pediatr 2000;39:195-201.
38. Weng WC, Peng SS, Wang SB, Chou YT, Lee WT. Mycoplasma pneumoniae-associated transverse myelitis and rhabdomyolysis. Pediatr Neurol 2009;40:128-130
39. Cunha BA. The atypical pneumonias: Clinical diagnosis and importance. Clin Microbiol Infect 2006;12:12-24.
40. Puljiz I, Kuzman I, Dakovic-Rode O, Schönwald N, Mise B. Chlamydia pneumonia and Mycoplasma pneumoniae pneumonia: Comparison of clinical, epidemiological characteristics and laboratory profilesm. Epidemiol Infect 2006;134:548-555
41. Ishida T, Miyashita N, Nakahama C. Clinical differentiation of atypical pneumonia using Japanese guidelines. Respirology 2007;12:104-110
42. Nisar N, Guleria R, Kumar S, Chand Chawla T, Ranjan Biswas N. Mycoplasma pneumoniae and its role in asthma. Postgrad Med J 2007;83:100-104
43. Lieberman D, Lieberman D, Printz S, Ben-Yaakov M, Lazarovich Z, Ohana B, et al. Atypical pathogen infection in adults with acute exacerbation of bronchial asthma. Am J Respir Crit Care Med 2003;167:406-410
44. Biscardi S, Lorrot M, Marc E, Moulin F, Boutonnat-Faucher B, Heilbronner C, et al. Mycoplasma pneumoniae and asthma in children. Clin Infect Dis 2004;38:1341-1346
45. Martin RJ, Kraft M, Chu HW, Berns EA, Cassell GH. A link between chronic asthma and chronic infection. J Allergy Clin Immunol 2001;107:595-601.
46. Kraft M, Cassell GH, Pak J, Martin RJ. Mycoplasma pneumoniae and C.pneumoniae in asthma: Effect of clarithromycin. Chest 2002;121:1782-1788
47. Varshney AK, Chaudhry R, Saharan S, Kabra SK, Dhawan B, Dar L, et al. Association of Mycoplasma pneumoniae and asthma among Indian children. FEMS Immunol Med Microbiol 2009;56:25-31.
48. Nei T, Yamano Y, Sakai F, Kudoh S. Mycoplasma pneumoniae pneumonia: Differential diagnosis by computerized tomography. Intern Med 2007;46:1083-1087
49. Daxboeck F, Krause R, Wenisch C. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin Microbial Infect 2003;9:263-273
50. Tully JG, Rose DL, Whitcomb RF, Wenzel RP. Enhanced isolation of Mycoplasma pneumoniae from throat washings with a newly-modified culture medium. J Infect Dis 1979;139:478-482
51. Gavranich JB, Chang AB. Antibodies for community acquired lower respiratory tract infections secondary to M.pneumoniae in children. Cochrane Database Syst Rev 2005;3:CD004875.
52. Margaret R. Hammerschlag Mycoplasma pneumoniae infections. Curr Opin Infect Dis 2001;14:181-186
53. Lind K, Lindhardt BO, Schutten HJ, Blom J, Christiansen C. Serological cross-reactions between M.genitalium and M.pneumoniae. J Clin Microbiol 1984;20:1036-1043
54. Andreu LM, Molinos AS, Fernandez RG, González SV, Ausina RV. Serologic diagnosis of Mycoplasma pneumoniae infections. Enferm Infect Microbiol Clin 2006;24:19-23.
55. Loens K, Ursi D, Goossens H, Ieven M. Molecular diagnosis of Mycoplasma pneumoniae respiratory tract infections. J Clin Microbiol 2003;41:4915-4923
56. Michelow IC, Olsen K, Lozano J, Duffy LB, McCracken GH, Hardy RD. Diagnostic utility and clinical significance of naso- and oro- pharyngeal samples used in a PCR assay to diagnosis Mycoplasma pneumoniae infection in children with community acquired pneumonia. J Clin Microbiol 2004;42:3339-3341
57. Gnarpe J, Lundback A, Sundelof B, Gnarpe H. Prevalence of Mycoplasma pneumoniae in subjectively healthy individuals. Scand J Infect Dis 1992;24:161-164
58. Reznikov M, Blackmore TK, Finlay-Jones JJ, Gordon DL. Comparison of nasopharyngeal aspirates and throat swab specimens in a polymerase chain reaction based test for Mycoplasma pneumonia. Eur J Clin Microbiol Infect Dis 1995;14:58-61.
59. Dorigo-Zetsma JW, Verkooyen RP, Van Helden HP, van der Nat H, van den Bosch JM. Molecular detection of Mycoplasma pneumoniae in adults with CAP requiring hospitalization. J Clin Microbiol 2001;39:1184-1186
60. Hardegger D, Nadal D, Bossart W, Altwegg M, Dutly F. Rapid detection of Mycoplasma pneumoniae in clinical samples by real-time PCR. J Microbiol Methods 2000;41:45-51.
61. Loens K, Beck T, Ursi D, Overdijk M, Sillekens P, Goossens H, et al. Development of real-time multiplex nucleic acid sequence based amplification for detection of M.pneumoniae, C.pneumoniae and Legionella species in respiratory specimens. J Clin Microbiol 2008;46:185-191
62. File TM Jr, Tan JS, Plouffe JF. The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophilia in respiratory infection. Infect Dis Clin North Am 1998;12:569-592
63. Taylor-Robinson D, Bebear C. Antibiotic susceptibilities of mycoplasmas and treatment of mycoplasmal infections. J Antimicrob Chemother 1997;40:622-630
64. Yamaguchi T, Hirakata Y, Izumikawa K, Miyazaki Y, Maesaki S, Tomono K, et al. In vitro activity of Telithromycin (HMR3647): A new ketolide, against clinical isolates of Mycoplasma pneumoniae in Japan. Antimicrob Agents Chemother 2000;44:1381-1382
65. Duffy LB, Crabb D, Searcey K, Kempf MC. Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma species. J Antimicrob Chemother 2000;45:s29-33.
66. Principi N, Esposito S. Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric respiratory tract infections. Lancet Infect Dis 2001;1:334-344 (Pubitemid 33586614)
67. Principi N, Esposito S, Blasi F, Allegra L; Mowgli study group. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community acquired LRT infections. Clin Infect Dis 2001;32:1281-1289 (Pubitemid 32405899)
68. Morozumi M, Hasegawa K, Kobayashi R, Inoue N, Iwata S, Kuroki H, et al. Emergence of vmacrolide resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation. Antimicrob Agents Chemother 2005;49:2302-2306
69. Matsuoka M, Narita M, Okazaki N, Ohya H, Yamazaki T, Ouchi K, et al. Characterization and molecular analysis of macrolide resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrobial Agents Chemother 2004;48:4624-4630
70. Gobel U, Butler GH, Stanbridge EJ. Comparative analysis of mycoplasmal ribosomal RNA operons. Isr J Med Sci 1984;20:762-764
71. Wolff BJ, Thacker WL, Schwartz SB, Winchell JM. Detection of macrolide resistance in M.pneumoniae by real-time PCR and high resolution melt analysis. Antimicrob Agents Chemother 2008;52:3542-3549
72. Hamamoto K, Shimizu T, Fujimoto N, Zhang Y, Arai S. In vitro activities of Moxifloxacin and other fluoroquinolones against M.pneumoniae. Antimicrob Agents Chemother 2001;45:1908-1910
73. Suzuki S, Yamakazi T, Narita M, Okazaki N, Suzuki I, Andoh T, et al. Clinical evaluation of macrolide resistant M.pneumoniae. Antimicrob Agents Chemother 2006;50:709-712
74. Waites KB, Crabb DM, Duffy LB. In vitro activities of ABT-773 and other antimicrobials against human mycoplasmas. Antimicrob Agents Chemother 2003;47:39-42.
75. Centers for disease control and prevention. Outbreak of CAP caused by M.pneumoniae: Colorado. JAMA 2000;285:2073-2074
76. Hyde TB, Gilbert M, Schwartz SB, Zell ER, Watt JP, Thacker WL, et al. Azithromycin prophylaxis during a hospital outbreak of M.pneumoniae pneumonia. J Infect Dis 2001;183:907-912
77. Daxboeck F. Mycoplasma pneumoniae CNS infections. Curr Opin Neurol 2006;19:374-378
78. Linchevski I, Klmenet E, Nir-Paz R. Mycoplasma pneumoniae vaccine protective efficacy and adverse reactions: Systemic review and meta-analysis. Vaccine 2009;27:2437-2446